Human schistosomiasis
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta analysis
17
Can human schistosomiasis mansoni control be sustained in high risk transmission foci in Egypt?
8
Epidemiology and control of human schistosomiasis in Tanzania
20
Infection with schistosome parasites in snails leads to increased predation by prawns: implications for human schistosomiasis control
6
Innate, adaptive and regulatory immune responses in human schistosomiasis in Gabon
156
Climate variability and spatiotemporel distributions of human schistosomiasis in region Marahoué (Côte d'Ivoire)
12
Immune responses during human Schistosomiasis mansoni Evidence for antiidiotypic T lymphocyte responsiveness
7
Schistosomiasis and Urothelial Bladder Carcinoma
6
Elimination of schistosomiasis: the tools required
9
ROLE OF ARGINASE ON THE PROGRESS OF SCHISTOSOMIASIS CAUSED BY SCHISTOSOMA MANSONI
6
RE ASSESSMENT OF THE PREVALENCE OF URINARY SCHISTOSOMIASIS IN AMAGUNZE, NKANU EAST LOCAL GOVERNMENT AREA OF ENUGU STATE
9
The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis
10
Deterministic and Stochastic Schistosomiasis Models with General Incidence
12
Drugs for treating urinary schistosomiasis
103
Schistosomiasis in Malawi: a systematic review
20
Optimising cluster survey design for planning schistosomiasis preventive chemotherapy
21
The epidemiology of Schistosomiasis in Lango Region Uganda 60 years after Schwetz 1951: Can Schistosomiasis be eliminated through Mass Drug Administration without other supportive control measures?
28
A Schistosomiasis Model with Diffusion Effects
12
Schistosomiasis vaccine discovery using immunomics
5
Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative assisted programmes
18